Many practices are still using offsite laboratories to process their patients Respiratory and Urinary Tract related cultures. The Point of Care PCR Joint Venture Program is revolutionizing the way both small and large practices increase monthly revenue. Often these facilities are not only billing the insurance carrier, they also send patients to collections. The Integration of this system will grant you billing privileges and the control of your patient’s financial outcome.

1. Advanced In-Office
PCR Testing
RESPIRATORY AND URINARY TRACT
INFECTIONS
Ancillary Revenue Opportunity

2. www.microbiodx.com 2
The Integration of this system will
grant you billing privileges and the
control of your patient’s financial
outcome.
IN-OFFICE POINT OF CARE PCR TESTING =
RAPIDLY INCREASED MONTHLY REVENUE
The Point of Care Joint Venture
Program is revolutionizing the way
large practices increase monthly
revenue.
Many practices are still using
offsite laboratories to process their
patients Respiratory and Urinary
Tract related cultures. Often these
facilities are not only billing the
insurance carrier, they also send
patients to collections.

3. www.microbiodx.com 3
TESTING BENEFITS
Test your patients in-office and get test
results during the same visit!
Determine if your patient needs
antibiotics.
Rapid same day test
results
Test results will provide the antibiotic
resistance of the organism that presents
as positive in your patients test results.
Stop using antibiotics that don’t cure
your patient.
Antibiotic resistance
read out
By integrating the point of care system
into your office. Your medical practice
will elevate with robust services,
increased treatment capabilities and
monthly revenue.
Test your patients on
a clinical level just
like the Laboratories.
We have designed this program to be
effortless on your part. We provide
• The setup (including your C.L.I.A
license)
• The device
• The technician
• The supplies
• The Billing
The Joint Venture
program is a complete
turnkey opportunity.
The CDC has started to mandate the use of antibiotic alternatives for long-term managed care.
By reducing the use of antibiotics patients will have less resistance when it is truly needed.
We have created a program that keeps you compliant with monthly reports. PCR testing will
help reduce the use of antibiotics and increase your facility health score. It is only a matter of
time before it is mandated at the clinical level.
Compliant with the Antibiotic stewardship program

4. www.microbiodx.com 4
Advanced PCR Technology
CDC Guideline on Rapid influenza test kits
(RIDTs)
“If an important clinical decision is affected
by the test result, the RIDTs result should
be confirmed by a molecular assay, such as
reverse transcription polymerase chain
reaction (RTPCR)”
96% more accurate than traditional culture
testing. The test is unaffected by the use of
antibiotics
Why use PCR
Technology
RPP is a qualitative test that will identify
DNA from respiratory viruses and bacteria
extracted from nasopharyngeal swabs from
individuals with clinical signs and symptoms
of a respiratory tract infection. This panel
employs PCR (polymerase chain reaction)
technology which is used to “amplify” small
quantities of nucleic acid into detectable
levels which leads to accurate results.
What is Respiratory
Panel Testing?
UTI (urinary tract infection) testing utilizes
quantitative Polymerase Chain Reaction
(PCR) to rapidly analyze your patient’s
sample. PCR technology precisely detects
the correct pathogen(s) and identifies
antibiotic drug resistance. This allows
providers the ability to prescribe timely and
effective treatment
What Is Urinary Tract
Infection Testing?

5. www.microbiodx.com 5
This test will prove if a patient has a virus
and does not require antibiotics, thereby
affirming a provider’s decision to avoid drugs
that are unnecessary and can have
significant side effects.
(THIS IS A CONSTANT STRUGGLE
FOR ALL PHYSICIANS.)

6. www.microbiodx.com 6
What does this mean for Your Practice?
Increased Clinical
Value
100%
Over prescription of
Antibiotics
0%
Timely, actionable
results
45
MINUTES Stop guessing and
start treating
IMMEDIATELY
No upfront cost
$0.00
SUCCESS
Just 8-10 tests a day can generate over $25K+ per
month in net revenue

7. www.microbiodx.com 7
How does the Joint Venture Work?
We provide all the following at zero cost for you.
Custom Insurance
Proforma evaluation
FREE
C.L.I.A Waived
License
FREE
Dedicated onsite
Technician
FREE
Point Of Care Testing
Device
FREE
All-inclusive Billing
FREE
Daily Revenue 8 samples per day X
$620.00
=
$4,960.00
Avg. Reimbursement per patient daily revenue
Monthly Revenue $4960.00 Daily X
22
=
$109,120.00
Working days per month monthly revenue
Cost to run
program daily
$265.00 per test daily (includes
reagents, Tech, billing, prior
auth, software, supplies, etc.)
X
8
=
$2,120
tests per day cost to run program daily
Cost to run
program monthly
$2,,120.00 Daily X
22
=
$46,640
working days per month monthly cost to run program daily
Net revenue
Monthly revenue $109,120.00
(Prior to expenses)
-$46,640.00 $62,480.00
(Monthly expenses) Net revenue to the program
Your investment
cost $0.00
50/50 split revenue Monthly revenue =
$31,240.00
to your facility
This complete turnkey system
will be a game changer for
your medical facility!
Our team gets you completely
setup. Your office will never
miss a beat, from site
certification to training we
will ensure that your Point of
Care service is ready for
immediate use.

8. www.microbiodx.com 8
In-Office RPP and UTI Testing Device
This well-known manufacture provides hardware for laboratories and hospitals
nationwide.
Integrate the Point of Care UTI and
RPP device today!
Start increasing your monthly
revenue with no out of pocket
expenses!
The program requires 6 feet of
dedicated desk space and a CLIA
Certificate.
The CLIA licensing is part of the
program and does not require any
upfront costs.

9. www.microbiodx.com 9
The Impact of UTI’s on Humanity and the
Healthcare System
~10 Million
Office Visits
per Year
23,000
Deaths
$13 Billion in
Costs
01 02 03
Up to 1/3 of all infections illustrate
resistance to antibiotics
Complications from UTI’s results in
9-11 days longer for each hospital
stay
• CandidiaAlbicans • Chlamydia Trachomatis • Neisseria Gonorrhoeae • Streptoccocusagalactia(group A) • Streptoccocuspyogenes(Group B) • Trichomonas Vaginalis •
Gardnerellavaginalis • Staphylococcus Aureus • *Mrsa(Methiciillianresistance) • Staphylococcus Saprophyticus • Serratiamarcescens • Proteus Mirabilis • Klebsiella Pneumoniae/
Oxytoca • Acinobacterbaumannii • Citrobacter Freundii/Braakii • Escherichia Coli • Pseudomonas Aeruginosa • Enetrococcusfaecium • Citrobacter Koseri • Class A Blactamase;
Blakpc • Class A B-lactamase; Ctx-m Group1 • Class B Metallo-b -Lactamase; Blandm • Vre; Vana • Vancomycin Resistance • Dna/ RnaAmplified Probe
UTI Pathogen Panel

10. www.microbiodx.com 10
It has been estimated
each year in the United
States the flu result in:
RESPIRATORY
BURDEN
31.4 Million
Outpatient Visits
About 200,000
Hospitalization
More than $87 Billion
in Total Economic
Burden
Between 3,000 to
49,000 Deaths
• Influenza Virus, A & B • Human metapneumovirus(A & B) • Rhinovirus species (types A & B) • Syncytial virus • Adenovirus species • Parainfluenza virus species (type 1-4) •
Coronavirus species (229E, HKU1, NL63, OC43) • Legionella Pneumophila • Mycoplasma Pneumoniae • Chlamydia Pneumoniae • Streptococcus, Group A • RSV, A & B •
Enterovirus species • Staphylococcus aureus • HaemophilusInfluenza • Moraxella catarrhalis • Streptococcus pneumoniae • Bordatellapertussis • Staphylococcus epidermis
Klebsiella pneumoniae • MRSA • Pneumocystis jirovecii • Coxiellaburnetii Antimicrobial Resistant Genes • VIM • CTX-M
RPP Pathogen Panel

11. www.microbiodx.com 11
The Process
• Complete pre-
qualification paperwork
• Schedule founders call to
review CPT codes
• Receive customized
proforma
• Schedule meeting with
practice to review
• Review Proforma with
practice
• Contract and credit app
signed
• Schedule licensing,
validation, and
implementation dates
• Schedule
Implementation meeting
• Onsite licensure and
validation
• Onsite Implementation
Go Time
Any questions please contact your Account Executive.

12. www.microbiodx.com 12
Mail away PCR
With mail away PCR advanced culture testing you will have more options available when testing your patients.
There are 12 panels to choose from.
• Detects Polymicrobial infections
• Pharmacist issued medication review
• Identifies the organism’s antibiotic
resistance
• Unaffected by current antibiotic use
• Reduces false negative results
• Aids in antibiotic stewardship
• CAP and CLIA accredited
• Authorizations done by laboratory
• Respiratory Pediatrics • Adults • STI • Immuno • UTI • UTI w/ STI • Women’s Health | Men’s Health • Gastroenterology • Wound Surgical •
Wound Nail • Eye ENT • CNS • Tick-Borne
Available Panel
Quantitative Real-Time PCR Technology
Identifies Poly organisms such as: Fungus, Viruses,
Parasites, and Bacteria with a 96% accuracy!
Even if the patient is already on Antibiotics.
The Rapid alternative to traditional culture testing!
Results in 24 Hours directly in your portal

13. THANK YOU
info@microbiodx.com www.microbiodx.com 800-848-7240